Author | Steven A. Rosenberg, MD, PhD


Management of Metastatic Cutaneous Melanoma

October 01, 2004

BySteven A. Rosenberg, MD, PhD

Although chemotherapy regimenscan produce objectiveresponses in patients withmetastatic melanoma, curative responsesare extremely rare. It is thereforeof significant interest that themajority of complete responses to immunotherapywith high-dose interleukin(IL)-2 (Proleukin) alone aredurable and probably curative.[1]